OpenEvidence's platform is freely available to all physicians, leading to widespread organic adoption and strategic partnerships with publishers like the New England Journal of Medicine.

OpenEvidence allows doctors to drill down to the underlying sources of information, fostering a symbiotic relationship with medical publishers by driving traffic to their journals.

The editorial board members of the New England Journal of Medicine were already power users of OpenEvidence, which led to their willingness to collaborate with us.

OpenEvidence serves not only elite hospitals but also community practices, providing essential medical knowledge to doctors in underserved areas who cannot afford expensive subscriptions.

OpenEvidence's approach to training AI models is distinct; it does not connect to the public internet, ensuring that the information provided is based solely on vetted medical research. Additionally, OpenEvidence has formed a strategic partnership with the New England Journal of Medicine, which is unique as they typically do not allow AI companies to train on their research.

OpenEvidence addresses the challenge of finding specific medical information by providing a streamlined way for doctors to access relevant studies and data, improving patient care outcomes.

OpenEvidence is trained on peer-reviewed medical literature, serving as an AI co-pilot that assists doctors in making better decisions at the point of care, which is undeniably beneficial for humanity.

Open Evidence is a medical search platform that has grown to support over 25% of US practicing physicians as monthly active users, with many using it daily for critical information.

OpenEvidence's growth is primarily driven by word-of-mouth among doctors, rather than traditional marketing strategies, similar to how Tesla gained traction by creating an exceptional product.